Researchers at PositiveID have created a prototype of a fully synthetic artificial glucose sensing system that can detect and respond to glucose levels in human plasma. The advance could play a key role in developing an artificial pancreas for patients with type 1 diabetes, the company's chairman and CEO said.
Firm develops glucose sensing system for artificial pancreas
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|